AU5368296A - Nitrosylated blood substitutes - Google Patents
Nitrosylated blood substitutesInfo
- Publication number
- AU5368296A AU5368296A AU53682/96A AU5368296A AU5368296A AU 5368296 A AU5368296 A AU 5368296A AU 53682/96 A AU53682/96 A AU 53682/96A AU 5368296 A AU5368296 A AU 5368296A AU 5368296 A AU5368296 A AU 5368296A
- Authority
- AU
- Australia
- Prior art keywords
- nitrosylated
- blood substitutes
- substitutes
- blood
- nitrosylated blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/42—Haemoglobins; Myoglobins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40972095A | 1995-03-24 | 1995-03-24 | |
US409720 | 1995-03-24 | ||
PCT/US1996/003866 WO1996030006A1 (en) | 1995-03-24 | 1996-03-25 | Nitrosylated blood substitutes |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5368296A true AU5368296A (en) | 1996-10-16 |
Family
ID=23621704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU53682/96A Abandoned AU5368296A (en) | 1995-03-24 | 1996-03-25 | Nitrosylated blood substitutes |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5368296A (en) |
WO (1) | WO1996030006A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6916471B2 (en) | 1995-09-15 | 2005-07-12 | Duke University | Red blood cells loaded with S-nitrosothiol and uses therefor |
US6197745B1 (en) | 1995-09-15 | 2001-03-06 | Duke University | Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
WO1998034955A1 (en) * | 1997-02-06 | 1998-08-13 | Duke University Medical Center | No-modified hemoglobins and uses therefor |
US6855691B1 (en) | 1995-09-15 | 2005-02-15 | Duke University | Methods for producing and using S-nitrosohemoglobins |
US6911427B1 (en) | 1995-09-15 | 2005-06-28 | Duke University | No-modified hemoglobins and uses therefore |
US6627738B2 (en) | 1995-09-15 | 2003-09-30 | Duke University | No-modified hemoglobins and uses therefor |
US6153186A (en) * | 1995-09-15 | 2000-11-28 | Duke University Medical Center | Red blood cells loaded with S-nitrosothiol and uses therefor |
AT405135B (en) | 1997-01-17 | 1999-05-25 | Immuno Ag | PREPARATION COMPREHENSIVE THIOL GROUP-PROTEINS |
JP2000230000A (en) * | 1999-02-08 | 2000-08-22 | Hokkaido Univ | Nitrogen monoxide metabolite-polyoxyalkylene- hemoglobin conjugate combination |
EP1575419B1 (en) * | 2002-12-12 | 2015-05-27 | Duke University | Forming iron nitrosyl hemoglobin |
AU2004257693B8 (en) | 2003-07-09 | 2009-08-13 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of nitrite salts for the treatment of cardiovascular conditions |
CA2486245C (en) | 2003-12-26 | 2013-01-08 | Nipro Corporation | Albumin having enhanced antimicrobial activity |
EP1863503B1 (en) | 2005-03-07 | 2019-05-22 | Sangart, Inc. | Composition for delivering carbon monoxide (co) and nitric ozide (no) co to tissue using heme proteins as carriers |
US8551536B2 (en) | 2007-08-31 | 2013-10-08 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5331209B2 (en) * | 1973-10-05 | 1978-09-01 | ||
US4609383A (en) * | 1984-09-24 | 1986-09-02 | Aquanautics Corporation | Apparatus and method for extracting oxygen from fluids |
-
1996
- 1996-03-25 AU AU53682/96A patent/AU5368296A/en not_active Abandoned
- 1996-03-25 WO PCT/US1996/003866 patent/WO1996030006A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1996030006A1 (en) | 1996-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5872696A (en) | Endoscope | |
AU7203496A (en) | Novel peptides | |
AU6412796A (en) | Osteosynthesis aid | |
AU4780596A (en) | Hemi-wheeled walker | |
AU4780896A (en) | Core-board | |
AU6513396A (en) | Insole | |
AU1030997A (en) | Taphane | |
AU4996696A (en) | 2-benzyl-3-arylbenzothiophenes | |
AU5368296A (en) | Nitrosylated blood substitutes | |
AU4427296A (en) | Novel peptide | |
AU4394396A (en) | Modified peptides | |
AU4382896A (en) | Acetylimidazobenzodiazepines | |
AU4396396A (en) | Baby-bathing aid | |
AU7520396A (en) | Abl-interactor protein | |
AU5284296A (en) | Immune-evading proteins | |
AU7423796A (en) | Novel stress proteins | |
AU3703995A (en) | Improved membrane | |
AUPN633695A0 (en) | Membrane | |
AU6153396A (en) | E6ap-binding proteins | |
AU5161296A (en) | Anti-haemorrhagic peptides | |
AU4569496A (en) | Tetralinyl- and indanyl-ethylamides | |
AU6789696A (en) | Fluorobutenic acid hydrazides | |
AU6516296A (en) | Novel quinoxaline- and quinoxalinylalkane-phosphonic acids | |
AU7121496A (en) | Footwear | |
AU6476398A (en) | Novel peptides |